PCI Biotech Holding ASA Strategic Asset Allocation Index
PCI Biotech Holding ASA strategic asset allocation index. PCI Biotech Holding ASA (PCIB) has a Strategic Asset Allocation Index of 6.8% as of June 2025. Strategic assets (PP&E of Nkr855.00K plus long-term investments of Nkr-) total Nkr855.00K, measured against net assets of Nkr12.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of PCI Biotech Holding ASA to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of PCI Biotech Holding ASA (2008–2024)
Strategic asset allocation index of PCI Biotech Holding ASA from 2008 to 2024. This chart shows how PCI Biotech Holding ASA's Strategic Asset Allocation Index has evolved across 16 annual periods from 2008 to 2024. As of June 2025, the index stands at 6.8%, representing strategic assets of Nkr855.00K against net assets of Nkr12.52 Million NOK. Check PCI Biotech Holding ASA tangible book value ratio to evaluate the tangible quality of the company's equity base.
PCI Biotech Holding ASA Strategic Asset Allocation Index by Year (2008–2024)
PCI Biotech Holding ASA strategic asset allocation index by year from 2008 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for PCI Biotech Holding ASA from 2008 to 2024, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PCIB market cap overview.
| Year | SAAI | Strategic Assets (NOK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 1.3% | Nkr310.00K | Nkr310.00K | Nkr- | Nkr23.45 Million | ▲ +0.6 pp |
| 2023 | 0.8% | Nkr297.00K | Nkr297.00K | Nkr- | Nkr39.04 Million | ▼ -0.5 pp |
| 2022 | 1.3% | Nkr723.00K | Nkr723.00K | Nkr- | Nkr57.40 Million | ▼ -5.5 pp |
| 2021 | 6.7% | Nkr7.66 Million | Nkr7.66 Million | Nkr- | Nkr113.79 Million | ▲ +2.5 pp |
| 2020 | 4.2% | Nkr7.99 Million | Nkr7.99 Million | Nkr- | Nkr189.24 Million | ▲ +1.8 pp |
| 2019 | 2.5% | Nkr6.28 Million | Nkr6.28 Million | Nkr- | Nkr254.83 Million | ▲ +2.5 pp |
| 2018 | 0.0% | Nkr17.00K | Nkr17.00K | Nkr- | Nkr339.95 Million | ▼ 0.0 pp |
| 2017 | 0.1% | Nkr22.00K | Nkr22.00K | Nkr- | Nkr41.84 Million | ▲ +0.0 pp |
| 2016 | 0.0% | Nkr5.00K | Nkr5.00K | Nkr- | Nkr13.09 Million | ▲ +0.0 pp |
| 2015 | 0.0% | Nkr10.00K | Nkr10.00K | Nkr- | Nkr44.28 Million | ▼ -0.1 pp |
| 2014 | 0.2% | Nkr14.00K | Nkr14.00K | Nkr- | Nkr9.11 Million | ▲ +0.1 pp |
| 2013 | 0.0% | Nkr18.00K | Nkr18.00K | Nkr- | Nkr43.40 Million | ▲ +0.0 pp |
| 2011 | 0.0% | Nkr17.00K | Nkr17.00K | Nkr- | Nkr92.53 Million | ▼ -0.1 pp |
| 2010 | 0.1% | Nkr78.00K | Nkr78.00K | Nkr- | Nkr105.42 Million | ▼ -0.4 pp |
| 2009 | 0.4% | Nkr153.00K | Nkr153.00K | Nkr- | Nkr35.08 Million | ▲ +0.2 pp |
| 2008 | 0.2% | Nkr119.00K | Nkr119.00K | Nkr- | Nkr49.30 Million | — |